Haichang Biotech

Hangzhou, China · Founded 2013 · Privately Held (backing)

Developer of nucleic acid therapeutics designed to advance biomedical science and improve human health outcomes. Haichang Biotech is based in Hangzhou, China and was founded in 2013. Its last reported valuation was $384 million in Dec 2024. It has raised $211 million.

Last reported valuation
$383.7M
Oct 2026
Priced at
—
Total raised
$210.7M
Last round
—

Who backs Haichang Biotech?

19 investors
InvestorType
Fortune CapitalVenture capital
Huatai Zijin InvestmentOther
Heda VenturesOther
Gang WangOther
Dongguan Songshan Lake Science City Venture CapitalOther
Beijing Yinhe Hanhai Investment Management—
Gaorong Ventures—
Guo Yuan Xiang—
Hangzhou White Oak Technology Innovation Partnership—
Jianxin Financial Asset Investment—
+ 9 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Haichang Biotech investors

19 investors are on record for Haichang Biotech, including Fortune Capital, Huatai Zijin Investment, Heda Ventures and Gang Wang.

Free account
More of Haichang Biotech with a free account
  • ·The complete investor list: 19 names
  • ·Watch Haichang Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like Haichang Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View